Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald W Verhaegh

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Theranostics|February 25, 2020
<sup>68</sup>Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging studyWim van Boxtel, Susanne Lütje, Ilse C H van Engen-van Grunsven, et al.
Oral Oncology|October 11, 2020
Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinomaWim van Boxtel, Maike J M Uijen, Gerald W Verhaegh, et al.
Molecular Oncology|April 2, 2021
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladderMaria V Luna-Velez, Jelmer J Dijkstra, Marina A Heuschkel, et al.
The Journal of Urology|September 23, 2014
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferationAgus Rizal A H Hamid, Gerald W Verhaegh, Frank P Smit, et al.
Frontiers in Oncology|September 7, 2021
Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate CancerAgus Rizal A H Hamid, Maria V Luna-Velez, Aleksandra M Dudek, et al.
The Prostate|August 28, 2015
The role of HOXC6 in prostate cancer developmentAgus Rizal A H Hamid, A Marije Hoogland, Frank Smit, et al.
BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder CancerJasper P Hof, Sita H Vermeulen, Antoine G van der Heijden, et al.
Oral Oncology|January 7, 2023
Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitorsGerben Lassche, Adriana C H van Engen-van Grunsven, Onno van Hooij, et al.
BMJ (Clinical Research Ed.)|February 27, 2010
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohortFrank J M van Kuppeveld, Arjan S de Jong, Kjerstin H Lanke, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Theranostics|February 25, 2020
<sup>68</sup>Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging studyWim van Boxtel, Susanne Lütje, Ilse C H van Engen-van Grunsven, et al.
Oral Oncology|October 11, 2020
Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinomaWim van Boxtel, Maike J M Uijen, Gerald W Verhaegh, et al.
Molecular Oncology|April 2, 2021
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladderMaria V Luna-Velez, Jelmer J Dijkstra, Marina A Heuschkel, et al.
The Journal of Urology|September 23, 2014
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferationAgus Rizal A H Hamid, Gerald W Verhaegh, Frank P Smit, et al.
Frontiers in Oncology|September 7, 2021
Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate CancerAgus Rizal A H Hamid, Maria V Luna-Velez, Aleksandra M Dudek, et al.
The Prostate|August 28, 2015
The role of HOXC6 in prostate cancer developmentAgus Rizal A H Hamid, A Marije Hoogland, Frank Smit, et al.
BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder CancerJasper P Hof, Sita H Vermeulen, Antoine G van der Heijden, et al.
Oral Oncology|January 7, 2023
Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitorsGerben Lassche, Adriana C H van Engen-van Grunsven, Onno van Hooij, et al.
BMJ (Clinical Research Ed.)|February 27, 2010
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohortFrank J M van Kuppeveld, Arjan S de Jong, Kjerstin H Lanke, et al.
Pageof 6